Geode Capital Management, LLC Genocea Biosciences, Inc. Transaction History

Geode Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.01 - $1.38 $2,917 - $402,591	-291,733 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.96 - $1.35 $81,458 - $114,551	84,853 Added 41.02%	291,733 $364,000
Q4 2021 Feb 11, 2022	BUY	$0.95 - $1.99 $19,891 - $41,666	20,938 Added 11.26%	206,880 $239,000
Q3 2021 Nov 12, 2021	BUY	$1.74 - $2.33 $10,836 - $14,511	6,228 Added 3.47%	185,942 $357,000
Q2 2021 Aug 13, 2021	BUY	$2.06 - $2.82 $12,992 - $17,785	6,307 Added 3.64%	179,714 $420,000
Q3 2020 Nov 13, 2020	BUY	$1.81 - $5.53 $7,974 - $24,365	4,406 Added 2.61%	173,407 $397,000
Q2 2020 Aug 13, 2020	BUY	$1.66 - $3.06 $29,939 - $55,190	18,036 Added 11.95%	169,001 $388,000
Q4 2019 Feb 13, 2020	BUY	$2.05 - $2.82 $3,858 - $5,307	1,882 Added 1.26%	150,965 $312,000
Q3 2019 Nov 12, 2019	BUY	$2.9 - $4.07 $346,022 - $485,624	119,318 Added 400.87%	149,083 $432,000
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.71 $103,284 - $199,723	29,765 New	29,765 $116,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.